Zobrazeno 1 - 10
of 14
pro vyhledávání: '"N A, Darmani"'
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/580eb9e8aba542b89eb28cb76e0f2486
Autor:
W. Zhong, N. A. Darmani
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Subtypes (1–4) of the hyperpolarization-activated cyclic nucleotide-gated (HCN) channels are widely expressed in the central and peripheral nervous systems, as well as the cells of smooth muscles in many organs. They mainly serve to regulate cellul
Externí odkaz:
https://doaj.org/article/c81000167fdb4144bd4c08c3ca874248
Autor:
W Zhong, N A Darmani
Publikováno v:
Journal of cellular signaling
Publikováno v:
Neurochemistry international. 122
To characterize mechanisms involved in neurokinin type 1 receptor (NK(1)R)-mediated emesis, we investigated the brainstem emetic signaling pathways following treating least shrews with the selective NK(1)R agonist GR73632. In addition to episodes of
Autor:
N. A. Darmani, A. A. Izzo, B. Degenhardt, M. Valenti, G. Scaglione, R. Capasso, I. Sorrentini, V. Di Marzo
Publikováno v:
Neuropharmacology 48 (2005): 1154–1163.
info:cnr-pdr/source/autori:N. A. Darmani, A. A. Izzo, B. Degenhardt, M. Valenti, G. Scaglione, R. Capasso, I. Sorrentini and V. Di Marzo/titolo:Involvement of the cannabimimetic compound, N-palmitoylethanolamine, in inflammatory and neuropathic conditions: A review of the available pre-clinical data, and first human studies/doi:/rivista:Neuropharmacology/anno:2005/pagina_da:1154/pagina_a:1163/intervallo_pagine:1154–1163/volume:48
info:cnr-pdr/source/autori:N. A. Darmani, A. A. Izzo, B. Degenhardt, M. Valenti, G. Scaglione, R. Capasso, I. Sorrentini and V. Di Marzo/titolo:Involvement of the cannabimimetic compound, N-palmitoylethanolamine, in inflammatory and neuropathic conditions: A review of the available pre-clinical data, and first human studies/doi:/rivista:Neuropharmacology/anno:2005/pagina_da:1154/pagina_a:1163/intervallo_pagine:1154–1163/volume:48
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=cnr_________::25198dd649b0a659bfbdc849ab1eb0b8
http://www.cnr.it/prodotto/i/15284
http://www.cnr.it/prodotto/i/15284
Publikováno v:
Comparative medicine. 51(6)
The least shrew is an established animal model for reproductive and pharmacologic research. Biologic reference data are needed to assess animal health status and provide a rationale for use of novel statistical programs to evaluate the effects of ora
Autor:
N A, Darmani, B, Ahmad
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 288(1)
Activation of 5-hydroxytryptamine1A (5-HT1A) receptors in rats produces hypothermia and a number of behaviors [hindleg abduction (HLA), lateral head-weaving (LHW), forepaw treading (FPT), flat body posture (FBP), rollover (RO), tremor (T), and straub
Autor:
N A, Darmani
Publikováno v:
Journal of neural transmission (Vienna, Austria : 1996). 105(6-7)
The head-twitch response (HTR) in rodents is considered to be a functional index for the activation of 5-HT2A receptors. Intraperitoneal administration of the silent and selective 5-HT1A receptor antagonist, WAY 100635, produced the HTR in mice in a
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 262(2)
The 5-hydroxytryptamine (5-HT)2 agonist (+/- )-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and antagonist ketanserin were evaluated for acute and chronic effects on the 5-HT2 receptor-mediated head-twitch response (HTR) in mice. A single dose
Publikováno v:
Scopus-Elsevier
The effects of beclamide on regional brain monoamine levels and radioligand binding have been studied in rats. One hour oral pre-treatment with beclamide (400 mg kg−1) increased rat striatal dopamine turnover by increasing the levels of its major m